This scoping review highlights the critical importance of effective hepatitis B vaccination for patients with CKD, a population at heightened risk of HBV infection and its sequelae due to compromised immune function and frequent healthcare exposures [2,3]. The gene discussed is PPIB; the disease is hepatitis A virus infection.